The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer—a pooled analysis of the randomised clinical trials PlanB and SUCCESS C - Concepedia

Concepedia

Publication | Open Access

The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer—a pooled analysis of the randomised clinical trials PlanB and SUCCESS C

DOI Full Paper Access

46

Citations

26

References

2022

Year

Amelie de Gregorio, Wolfgang Janni, Thomas W. P. Friedl, Ulrike Nitz, Brigitte Rack, Andreas Schneeweiß, Ronald Kates, Tanja Fehm, Hans Kreipe, Matthias Christgen,

British Journal of Cancer

References

	Year	Citations

Page 1